V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007631 | 300004631 | 1.8 | null | Neo-adjuvant (N) | 2013-05-21 | 2013-08-03 | Melphalan IV High dose | N | N | 300017099 | CARBOPLATIN |
| 300007632 | 300004633 | 1.73 | 54.3 | Curative (C) | null | 2014-01-27 | Trial Unspecified | N | N | 300017103 | OXALIPLATIN + MDG |
| 300007633 | 300004636 | 1.78 | 60 | Neo-adjuvant (N) | 2017-06-01 | 2017-07-02 | Oxaliplatin + Modified de Gramont | N | null | 300017106 | CISPLATIN |
| 300007634 | 300004639 | 1.7 | null | Neo-adjuvant (N) | 2014-08-08 | 2014-08-30 | Capecitabine | 02 | N | 300017108 | TRIAL |
| 300007635 | 300004640 | null | 73.1 | Palliative (P) | 2015-10-26 | 2015-10-29 | Fluorouricil + Folonic Acid (MdG) | N | N | 300017110 | LOMUSTINE |
| 300007636 | 300006920 | 1.94 | 85.5 | Palliative (P) | 2017-06-29 | 2017-08-04 | Cisplatin +Fluorouracil (3 wk) | Y | N | 300017117 | IRINOTECAN + MDG |
| 300007637 | 300004646 | 1.73 | 94.7 | null | 2014-07-19 | 2014-07-26 | Capecitabine | 01 | N | 300017149 | CARBOPLATIN + ETOPOSIDE |
| 300007638 | 300004647 | 1.6 | 44.8 | Not known (9) | 2017-02-03 | 2017-02-10 | Carboplatin AUC 2 - 5 | N | Y | 300017151 | CETUXIMAB |
| 300007639 | 300004653 | 1.55 | 44.4 | Neo-adjuvant (N) | 2016-01-02 | 2016-04-16 | CISPLATIN + FLUOROURACIL | N | null | 300017221 | CARBOPLATIN |
| 300007640 | 300004655 | null | 80 | Palliative (P) | 2017-05-31 | 2017-06-11 | Capecitabine + Oxaliplatin 21day | Y | N | 300017222 | EVEROLIMUS |
| 300007641 | 300004657 | 1.71 | 62.799 | null | 2014-02-10 | 2014-02-26 | CARBOPLATIN + RT | N | Y | 300017241 | CAPECITABINE |
| 300007642 | 300004658 | 1.62 | 64 | Neo-adjuvant (N) | 2012-04-26 | 2013-10-03 | ESPAC-4 TRIAL | N | N | 300017245 | CARBOPLATIN |
| 300007643 | 300004663 | null | 51.3 | Curative (C) | 2014-04-15 | 2014-04-24 | CARBOPLATIN + RT | N | Y | 300017270 | CARBOPLATIN + RT |
| 300007645 | 300004665 | 1.62 | 56.3 | Disease modification (D) | 2014-07-15 | 2015-08-09 | TEMOZOLOMIDE | Y | N | 300017279 | CARBOPLATIN + PACLITAXEL |
| 300007646 | 300006932 | 1.65 | 70.6 | Curative (C) | null | 2016-10-15 | CARBOPLATIN + RT | N | Y | 300017287 | CETUXIMAB + RT |
| 300007647 | 300006932 | 1.71 | null | Palliative (P) | 2014-01-01 | 2014-01-31 | Capecitabine | N | null | 300017287 | CETUXIMAB |
| 300007648 | 300004670 | 1.63 | null | Curative (C) | 2014-05-22 | 2014-05-24 | Cisplatin | 02 | null | 300017300 | CARBOPLATIN |
| 300007649 | 300004673 | null | 79.3 | Adjuvant (A) | null | 2017-12-03 | Trial Unspecified | null | null | 300017307 | CISPLATIN + FLUOROURACIL |
| 300007650 | 300007775 | 1.73 | null | Curative (C) | 2014-06-15 | 2014-06-16 | Gemcitabine + Oxaliplatin | N | N | 300017312 | CAV |
| 300007651 | 300004674 | 1.62 | 54.8 | Palliative (P) | 2015-12-20 | 2015-12-31 | CARBOPLATIN + GEMCITABINE | 01 | N | 300017327 | CYTARABINE INTRATHECAL |
| 300007652 | 300004679 | null | 76.3 | Neo-adjuvant (N) | 2013-10-05 | 2013-10-19 | Carboplatin AUC 2 - 5 | 2 | N | 300017353 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007653 | 300004681 | 1.55 | null | Palliative (P) | 2017-02-12 | 2017-03-10 | CISPLATIN + FLUOROURACIL | null | null | 300017359 | CAPECITABINE |
| 300007654 | 300004683 | 1.9 | 73 | Disease modification (D) | 2015-01-18 | 2015-01-25 | Carboplatin AUC 2 - 5 | 2 | N | 300017380 | FCR |
| 300007655 | 300004685 | 1.46 | 59.1 | Palliative (P) | 2016-08-15 | 2016-10-03 | CISPLATIN + FLUOROURACIL | Y | N | 300017393 | CAPECITABINE + OXALIPLATIN |
| 300007656 | 300004687 | 1.52 | 67.1 | Palliative (P) | 2019-03-30 | 2019-04-01 | Carboplatin AUC 6 - 10 | null | Y | 300017397 | CAPECITABINE |
| 300007657 | 300004689 | 1.57 | 52.7 | null | null | 2018-02-06 | CARBOPLATIN + PACLITAXEL | null | null | 300017403 | CARBOPLATIN + PACLITAXEL |
| 300007658 | 300004691 | 0 | 77 | Neo-adjuvant (N) | 2014-11-20 | 2014-11-30 | Carbo F | N | N | 300017426 | CETUXIMAB + RT |
| 300007659 | 300004695 | 1.7 | null | Palliative (P) | 2017-08-29 | 2017-09-01 | PACLITAXEL | N | null | 300017445 | CAPECITABINE |
| 300007660 | 300004697 | 0 | null | Disease modification (D) | 2014-08-10 | 2014-08-18 | VAI (Ifos 3g/m2) | 02 | null | 300017468 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007661 | 300004701 | 1.77 | 68 | Palliative (P) | 2017-09-30 | 2017-10-20 | NAB PACLITAXEL | 2 | N | 300017481 | OXALIPLATIN + MDG |
| 300007662 | 300004703 | 1.5 | 101.7 | null | 2015-01-16 | 2015-06-06 | Cetuximab + Radiotherapy Maint | 02 | Y | 300017495 | CARBOPLATIN + CETUXIMAB + FU |
| 300007663 | 300004706 | 1.67 | null | Neo-adjuvant (N) | 2014-11-21 | 2014-11-26 | CISPLATIN + FLUOROURACIL | 02 | N | 300017511 | CARBOPLATIN + PACLITAXEL |
| 300007664 | 300007782 | 1.5 | 55.4 | Palliative (P) | 2017-06-08 | 2017-06-14 | CISPLATIN + FLUOROURACIL | N | N | 300017536 | CISPLATIN + FLUOROURACIL |
| 300007665 | 300004712 | null | 71.9 | Neo-adjuvant (N) | 2017-06-13 | 2018-01-17 | Cetuximab 7 day (>Cycle 2) | N | Y | 300017545 | CETUXIMAB + RT |
| 300007666 | 300004714 | 1.79 | 83.1 | Neo-adjuvant (N) | 2013-04-30 | 2013-05-04 | Folfirinox | 02 | N | 300017561 | CARBOPLATIN + CETUXIMAB + FU |
| 300007667 | 300004716 | null | 58 | Adjuvant (A) | 2015-12-13 | 2016-02-23 | KESTREL Trial | 02 | N | 300017581 | CAPECITABINE + GEMCITABINE |
| 300007668 | 300004723 | 1.6 | 47 | Palliative (P) | 2015-09-17 | 2015-09-17 | ESPAC-4 TRIAL | N | N | 300017655 | ESPAC TRIAL |
| 300007669 | 300004726 | null | 82.2 | Curative (C) | 2016-10-04 | 2016-10-17 | GEMCARBO | 02 | Y | 300017661 | CARBOPLATIN + CETUXIMAB + FU |
| 300007670 | 300004728 | 1.64 | 51.8 | Palliative (P) | 2014-05-06 | 2014-06-21 | NIVOLUMAB | N | N | 300017685 | TRIAL |
| 300007671 | 300004732 | 1.83 | null | Palliative (P) | null | 2014-01-17 | PEMBROLIZUMAB | N | null | 300017710 | CAPECITABINE |
| 300007672 | 300004736 | 1.62 | 107.3 | Neo-adjuvant (N) | 2016-09-12 | 2016-09-22 | CAPECITABINE + GEMCITABINE | N | N | 300017727 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300007673 | 300004738 | 1.65 | 44.6 | null | 2012-07-26 | 2016-08-17 | Cetuximab 7 day (>Cycle 2) | 02 | N | 300017751 | CAPECITABINE + OXALIPLATIN |
| 300007674 | 300004740 | 1.6 | 54.4 | Neo-adjuvant (N) | 2016-01-21 | 2016-01-26 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 300017752 | NOT MATCHED |
| 300007675 | 300004741 | 1.78 | 68 | Neo-adjuvant (N) | 2015-11-01 | 2015-12-13 | NIVOLUMAB | N | N | 300017758 | CETUXIMAB |
| 300007676 | 300004745 | 1.75 | 96.95 | null | 2014-06-09 | 2014-07-26 | Trial Unspecified | N | null | 300017779 | CARBOPLATIN + RT |
| 300007677 | 300004746 | 0 | 51.2 | Palliative (P) | 2013-03-24 | 2013-04-14 | CISPLATIN + FLUOROURACIL | 2 | N | 300017783 | CAPECITABINE + MITOMYCIN |
| 300007678 | 300004749 | 1.83 | 65 | Neo-adjuvant (N) | 2016-01-16 | 2016-06-09 | OXALIPLATIN | N | null | 300017811 | NOT MATCHED |
| 300007679 | 300004750 | null | null | Curative (C) | 2018-05-09 | 2018-05-23 | Cetuximab 7 day (>Cycle 2) | N | Y | 300017813 | CISPLATIN + FLUOROURACIL |
| 300007680 | 300004751 | null | null | Not known (9) | 2017-03-01 | 2017-03-17 | Cisplatin 7 day | N | null | 300017826 | CETUXIMAB |
| 300007681 | 300006967 | 1.73 | 101.8 | null | null | 2016-04-05 | CARBOPLATIN | N | Y | 300017829 | CAPECITABINE |